The Journal of Pain
Volume 10, Issue 11 , Pages 1128-1137 , November 2009

Diagnosis-Specific Management of Somatoform Disorders: Moving Beyond “Vague Complaints of Pain”

  • Anne Dohrenwend

      Affiliations

    • Department of Medicine, Michigan State University, College of Human Medicine, McLaren Regional Medical Center, Flint, Michigan
    • Corresponding Author InformationAddress reprint requests to Dr Anne Dohrenwend, McLaren Internal Medicine Residency Program, 3230 Beecher Road, Suite 2, Flint, MI 48532.
    • ,
  • Jared Lyon Skillings

      Affiliations

    • Department of Family Medicine and Public Health Sciences, Wayne State University, School of Medicine, Crittenton Hospital Medical Center, Rochester Hills, Michigan

References 

  1. Abbey S. Somatization and somatoform disorders. In:  Levenson J editors. The American Psychiatric Publishing Textbook of Psychosomatic Medicine. Washington, DC; 2005;p. 271–296
  2. Adler R, Zamboni P, Hofer T, Hemmeler W. How not to miss a somatic needle in a haystack of chronic pain. J Psychosom Res. 1997;42:499–505
  3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision (DSM-IV-TR). Washington, DC, APA, 2000
  4. Arnold B, Alpers G, Süss H, Friedel E, Kosmützky G, Geier A, et al. Affective pain modulation in fibromyalgia, somatoform pain disorder, back pain, and healthy controls. Eur J Pain. 2008;12:329–338
  5. Barsky A, Ahern D. Cognitive behavioral therapy for hypochondriasis: A randomized controlled trial. JAMA. 2004;291:1464–1470
  6. Barsky A, Fama J, Bailey E, Ahern D. A prospective 4- to 5- year study of DSM-III-R hypochondriasis. Arch Gen Psychiatry. 1998;55:737–744
  7. Barsky A, Orav E, Bates D. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry. 2005;62:903–910
  8. Barskey A, Wyshak G. Hypochondriasis and somatosensory amplification. Br J Psychiatry. 1990;157:404–409
  9. Bienvenu O, Samuels J, Riddle M, Hoehn-Saric R, Liang K, Cullen B, et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: Results from a family study. Biol Psychiatry. 2000;48:287–293
  10. Bohne A, Keuthen N, Wilheim S, Deckersback T, Jenike M. Prevalence of symptoms of body dysmorphic disorder and its correlates: A cross-cultural comparison. Psychosomatics. 2002;43:486–490
  11. Butcher J. Minnesota Multiphasic Personality Inventory-2, User's Guide, the Minnesota Report: Adult Clinical System. Minneapolis, MN: National Computer Systems; 1989;
  12. Creed F, Barsky A. A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res. 2004;56:391–408
  13. deWaal M, Arnold I, Eekhof J, van Hemert A. Somatoform disorders in general practice: Prevalence, functional impairment with comorbidity with anxiety and depressive disorders. Br J Psychiatry. 2004;184:470–476
  14. Eifert G, Zvolensky M. Somatoform disorders. In:  Winstead B,  Maddux J editor. Psychopathology: Foundations for a Contemporary Understanding. Mahwah, NJ: Lawrence Erlbaum Associates; 2005;p. 281–300
  15. Eisen J, Phillips K, Coles M, Rasmussen S. Insight in obsessive compulsive disorder and body dysmorphic disorder. Compr Psychiatry. 2004;45:10–15
  16. Epstein R, Quill T, McWhinney I. Somatization reconsidered: Incorporating the patient's experience of illness. Arch Intern Med. 1999;159:215–222
  17. Fackler S, Anfinson T, Rand J. Serial sodium amytal interviews in the clinical setting. Psychosomatics. 1997;38:558
  18. Fink P, Hansen M, Oxhoj M-L. The prevalence of somatoform disorders among internal medical patients. J Psychosom Res. 2004;56:413–418
  19. Fishbain D. Polypharmacy treatment approaches to the psychiatric and somatic comorbidities found in patients with chronic pain. Am J Phys Med Rehabil. 2005;84:S56–S63
  20. Fishbain D. Approaches to treatment decisions for psychiatric comorbidity in the management of the chronic pain patient. Med Clin North Am. 1999;83:737–760
  21. Ford C. Deception syndromes: Factitious disorders and malingering. In:  Levenson J editors. The American Psychiatric Publishing Textbook of Psychosomatic Medicine. Washington, DC: American Psychiatric Publishing; 2005;p. 297–309
  22. Guggenheim F. Somatoform disorders. In:  Sadock B,  Sadock V editor. Comprehensive Textbook of Psychiatry. 7th Edition. Philadelphia, Lippincott: Williams & Wilkins; 2000;p. 1504–1532
  23. Guggenheim F, Smith G. Somatoform Disorders. In:  Kaplan H,  Sadock B editor. Comprehensive Textbook of Psychiatry. 6th ed. Baltimore: Williams, & Wilkins; 1995;p. 1251–1270
  24. Hahn S, Thompson K, Wills T, Stern V, Budner N. The difficult doctor-patient relationship: Somatization, personality and psychopathology. J Clin Epidemiol. 1994;47:647–657
  25. Hellman C, Budd M, Borysenko J, McClelland D, Benson H. A study of the effectiveness of two group behavioral medicine interventions for patients with psychosomatic complaints. Behav Med. 1990;8:165–173
  26. Henningsen P, Jakobsen T, Schiltenwolf M, Weiss M. Somatization revisited: Diagnosis and perceived causes of common mental disorders. J Nerv Ment Dis. 2005;193:85–92
  27. Jacobi F, Wittchen H, Hölting C, Höfler M, Pfister H, Müller N, et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: Results from the German Health Interview and Examination Survey (GHS). Psychol Med. 2004;34:597–611
  28. Keeley R, Smith M, Miller J. Somatoform symptoms and treatment nonadherence in depressed family medicine outpatients. Arch Fam Med. 2000;9:46–54
  29. Kirmayer L, Robbins J, Paris J. Somatoform disorders: Personality and the social matrix of somatic distress. J Abnorm Psychol. 1994;103:125–136
  30. Krahn L, Hongzhe L, O'Connor M. Patients who strive to be ill: Factitious disorder with physical symptoms. Am J Psychiatry. 2003;160:1163–1168
  31. Kroenke K, Arrington ME, Mangelsdorff AD. The prevalence of symptoms in medical outpatients and the adequacy of therapy. Arch Intern Med. 1990;150:1685–1689
  32. Kroenke K, Price R. Symptoms in the community: Prevalence, classification, and psychiatric comorbidity. Arch Intern Med. 1993;153:2474–2480
  33. Kroenke K, Sharp M, Sykes R. Revising the classification of somatoform disorders: Key questions and preliminary recommendations. Psychosomatics. 2007;48:277–285
  34. Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: A critical review of controlled clinical trials. Psychother Psychosom. 2000;69:205–215
  35. Lazare A. Conversion symptoms. N Engl J Med. 1981;305:745
  36. Leichsenring F, Leibing E. The effectiveness of psychodynamic therapy and cognitive behavior therapy in the treatment of personality disorders: A meta-analysis. Am J Psychiatry. 2003;160:1223–1232
  37. Lidbeck J. Group therapy for somatization disorders in general practice: Effectiveness of a short cognitive-behavioral treatment model. Acta Psychiatr Scand. 1997;96:14–24
  38. Lipowski Z. Somatization: The concept and its clinical application. Am J Psychiatry. 1988;145:1358–1368
  39. Manchikanti L, Giordano J, Boswell M, Fellows B, Manchukonda R, Pampati V. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manag. 2007;3:89–100
  40. Mayou R, Kirmayer L, Simon G, Kroenke K, Sharpe M. Somatoform disorders: Time for a new approach in DSM-V. Am J Psychiatry. 2005;162:847–855
  41. Miller M. What is body dysmorphic disorder?. Harvard Mental Health Letter. July 1, 2005;
  42. Millon T, Antoni M, Millon C, Meagher S, Grossman S. Millon Behavioral Medicine Diagnostic Manual. Minneapolis, MN: NCS Pearson, Inc; 2001;
  43. Moss-Morris R, Humphrey K, Johnson M, Petrie K. Patients' Perceptions of Their Pain Condition Across a Multidisciplinary Pain Management Program: Do They Change and If So Does It Matter?. Clin J Pain. 2007;23:558–564
  44. Neziroglu F, McKay D, Todaro J, Yaryura-Tobias J. Effect of cognitive behavior therapy on persons with body dysmorphic disorder and comorbid Axis II diagnoses. Behav Ther. 1996;27:67–77
  45. Ovsiew F. Hysteria in neurological practice: The somatoform and dissociative disorders. In:  Jeste D,  Friedman J editor. Psychiatry for Neurologists. Totowa, NJ: Humana Press; 2006;p. 67–80
  46. Perugi G, Akiskal H, Giannotti D, Frare F, DiVaio S, Cassano G. Gender-related differences in body dysmorphic disorder (dysmorphophobia). J Nerv Ment Dis. 1997;185:578–582
  47. Phillips K, McElroy S, Dwight M, Eisen J, Rasmussen S. Delusionality and response to open-label fluvoxamine in body dysmorphic disorder. J Clin Psychiatry. 2001;62:87–91
  48. Phillips KA, Menard W. Suicidality in body dysmorphic disorder: A prospective study. Am J Psychiatry. 2006;163:1280–1282
  49. Reich P, Gottfried L. Factitious disorders in a teaching hospital. Ann Intern Med. 1983;99:240–247
  50. Sansone R, Wiederman M, Sansone L. Medically self-harming behavior and its relationship to borderline personality symptoms and somatic preoccupation among internal medicine patients. J Nerv Ment Dis. 2000;188:45–47
  51. Sharpe M. Cognitive behavioral therapies in the treatment of functional somatic symptoms. In:  Mayou R,  Bass C,  Sharpe M editor. Treatment of functional somatic syndromes. Oxford, England: Oxford University Press; 1995;p. 122–143
  52. Smith R. Somatization disorder: Defining its role in clinical medicine. J Gen Intern Med. 1991;6:168–175
  53. Smith GC, Clarke DM, Handrinos D, McKenzie DP. Consultation-liaison psychiatrists' management of somatoform disorders. Psychosomatics. 2000;41:481–489
  54. Smith R, Gardiner J, Lyles J, Sirbu C, Dwamena F, Hodges A, et al. Exploration of DSM-IV Criteria in primary care patients with medically unexplained symptoms. Psychosom Med. 2005;67:123–129
  55. Smith G, Monson R, Ray D. Patients with multiple unexplained symptoms: Their characteristics, functional health, and health care utilization. Arch Intern Med. 1986;146:69–72
  56. Smith G, Rost K, Kashner T. A trial of the effect of a standardized psychiatric consultation on health outcomes and costs in somaticizing patients. Arch Gen Psychiatry. 1995;52:238–243
  57. Stern R, Fernandez M. Group cognitive and behavioral treatment for hypochondriasis. Br Med J. 1991;303:1229–1231
  58. Strassnig M, Stowell K, First M, Pincus H. General medical and psychiatric perspectives on somatoform disorders: Separated by an uncommon language. Curr Opin Psychiatry. 2006;19:194–200
  59. Sutherland A, Rodin G. Factitious disorders in a general hospital setting: Clinical features and a review of the literature. Psychosomatics. 1990;31:392–399
  60. Veale D. Outcome of cosmetic surgery and “DIY” surgery in patients with body dysmorphic disorder. Psychiatric Bull. 2000;24:218–221
  61. Von Korff M, Lin E, Fenton J, Saunders K. Frequency and priority of pain patients' health care use. Clin J Pain. 2007;23:400–408

PII: S1526-5900(09)00480-5

doi: 10.1016/j.jpain.2009.04.004

The Journal of Pain
Volume 10, Issue 11 , Pages 1128-1137 , November 2009

Article Tools